Metropolis Healthcare Limited (BOM:542650)
India · Delayed Price · Currency is INR 484.80
+9.20 (1.93%)
At close: Apr 21, 2026
Metropolis Healthcare Market Cap
Metropolis Healthcare has a market cap or net worth of 98.82 billion as of April 22, 2026. Its market cap has increased by 21.65% in one year.
Market Cap
98.82B
Enterprise Value
100.14B
Revenue
15.66B
Ranking
n/a
PE Ratio
58.73
Stock Price
484.80
Market Cap Chart
Since April 15, 2019, Metropolis Healthcare's market cap has increased from 48.16B to 98.82B, an increase of 105.18%. That is a compound annual growth rate of 10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 100.41B | 0.45% |
| Dec 31, 2025 | 99.96B | -6.11% |
| Dec 31, 2024 | 106.46B | 23.85% |
| Dec 29, 2023 | 85.96B | 26.46% |
| Dec 30, 2022 | 67.98B | -61.39% |
| Dec 31, 2021 | 176.07B | 75.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thyrocare Technologies | 62.49B |
| One Global Service Provider | 11.56B |
| Chandan Healthcare | 6.23B |
| Star Imaging and Path Lab | 1.32B |
| Modern Diagnostic & Research Centre | 1.17B |
| Invicta Diagnostic | 980.61M |
| Aspira Pathlab & Diagnostics | 576.51M |
| Family Care Hospitals | 172.85M |